2018 Press Releases

February 12, 2018

Humanetics Corporation Presents at BIO CEO and Investor Conference

January 11, 2018

Vice Admiral Matthew L. Nathan, M.D., Former Surgeon General of the U.S. Navy, Joins HUMANETICS Medical advisory board

January 30, 2018

Humanetics Corporation Presents Data on Drug to Protect Cardiac Cells Against Toxicity from Space-like Radiation

2017 Press Releases

October 31, 2017

Humanetics Presents Data on Cancer Drug

October 10, 2017

Humanetics Receives Grant From NASA

September 26, 2017

Humanetics Received $3.8 Million Grant from Department of Defense

September 12, 2017

Humanetics Awarded Patent for Cancer Treatment Drug

August 22, 2017

Humanetics to Present at Department of Defense Scientific Meeting

January 24, 2017

Humanetics Awarded Patent to Mitigate Erectile Dysfunction Associated with Prostate Cancer Radiotherapy

2016 Press Releases

August 10, 2016

Humanetics Received New Federal Grant to Continue Development of Radiation Countermeasure

May 17, 2016

Space Institute to Fund Testing of Radiation Protectants

2015 Press Releases

June 2, 2015

Humanetics Corporation Granted FDA Clearance To Proceed With Cancer Treatment Study

February 12, 2015

Humanetics Corportation Developing Compound That Could Protect Against Damage Caused by CT Scans and X-Rays

2014 Press Releases

July 9, 2014

New Grant Enables Humanetics Corporation to Evaluate Potential Treatment for Erectile Dysfunction in Prostate Cancer Patients

February 25, 2014

Corporation Enters Into Cooperative Research and Developement Agreement with the U.S. Army Medical Research Institute of Chemical Defense

January 14, 2014

Humanetics Corporation Granted Approval by the National Cancer Institute to Proceed with Cancer Treatment Study

2013 Press Releases

October 15, 2013

Humanetics Corporation Awarded Patient Enabling Oral Administration of Powerful Radioprotectant

2012 Press Releases

October 2, 2012

Humanetics Awarded Contract With National Cancer Institute

2011 Press Releases

June 1, 2011

BARDA Funds Development of Drug to Prevent Radiation Lung Injury

2010 Press Releases

November 10, 2010

Humanetics Awarded Two Grants from Qualifying Therapeutic Discovery Project

August 12, 2010

Humanetics Awarded Exclusive Worldwide Licenses from Henry Ford Health System for two Post-Exposure Medical Radiation Countermeasures

March 5, 2010

Patent Issued For Humanetics’ BIO 300 Radiation Countermeasure Drug

2008 Press Releases

January 11, 2008

Humanetics Completes Phase I Safety and Pharmacokinetic Trial for New Radiation Countermeasure

2007 Press Releases

November 13, 2007

Humanetics Receives $3.8 Million from U.S. Department of Defense to Continue Development of Medical Radiation Countermeasures

July 20, 2007

Humanetics Receives Orphan Drug Designation for Its BIO 300 Radiation Countermeasure

January 25, 2007

Humanetics Announces Sale of its Clinical Research Organization

January 11, 2007

FDA Clears Humanetics’ IND Filing to Commence Clinical Studies on New Radiation Countermeasure

2006 Press Releases

February 23, 2006

Humanetics Responds To Request For Radiation Countermeasures From Department Of Health & Human Services

February 16, 2006

Humanetics Corp Expands Dept Of Defense (DOD) Relationships With Response to Request from Missle & Space Command.

January 12, 2006

General Richard Neal, Former U.S. Marine Corps Asst Commandant, Named as Director of Humanetics Corporation

2005 Press Releases

December 8, 2005

Humanetics and the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Sign Exclusive License for Oral Agent to Protect and Stregthen the Immune System Against Radiation Exposure in Terrorist Attack

October 9, 2005

Humanetics Receives Additional $1.8 Million in Funding From Department of Defense for Development of Oral Drug to Protect Against Radiation.

Febuary 10, 2005

Unique Master Cooperative Research and Development Agreement Signed